Nventric Showcases Cutting-Edge Medical Technology At Healthcare Expo Taiwan 2025
Building on its mission to transform patient care through technology, Nventric will present its newest product developments designed to enhance precision, safety, and clinical outcomes in interventional procedures. With R&D in USA, and ISO 13485–certified manufacturing in South Korea, the company exemplifies global collaboration and uncompromising quality in every stage of product development.
“We are thrilled to join Healthcare Expo Taiwan 2025 and share our vision for the future of interventional medicine,” said Don Ngo, Sr. Director, Engineering & Operations of Nventric.“Our goal is to empower healthcare professionals with high-performance solutions that improve outcomes and redefine standards of care.”
At the expo, Nventric will highlight its end-to-end development capabilities, spanning concept design, prototyping, clinical validation, and commercialization. The company also welcomes new OEM and CDRMO partnerships for co-development of innovative devices in the neurovascular and cardiovascular fields.
Nventric's portfolio includes advanced devices such as distal access catheters, balloon guiding catheters, revascularization systems, and electrophysiology catheters-all engineered with precision and reliability to support the most demanding clinical applications.
About Nventric
At Nventric, we drive innovation in medical technology to transform patient care and improve lives worldwide. Specializing in neurovascular, coronary, electrophysiology, and peripheral solutions, Nventric combines engineering excellence with global expertise to deliver end-to-end device development - from concept to commercialization.
Learn more:
R&D in the USA. Manufactured in South Korea. ISO 13485 Certified. GMP. Product pending FDA approval.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment